(Q34267128)

1 August 2017

1 reference

title

Preventing gastrointestinal complications of NSAIDs. Risk factors, recent advances, and latest strategies (English)

1 reference

1 August 2017

J F Graumlich

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

1 August 2017

published in

Postgraduate Medicine

1 reference

1 August 2017

volume

109

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

117-20, 123-8

1 reference

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Nonsteroidal anti-inflammatory drug gastropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Prophylaxis and treatment of NSAID-induced gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Non-NSAID pharmacologic treatment options for the management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.05.931

21 January 2018

Identifiers

DOI

10.3810/PGM.2001.05.931

1 reference

1 August 2017

1 reference